{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:09:21Z","timestamp":1793279361865,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ophtha.2011.09.038","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T09:30:35Z","timestamp":1324546235000},"page":"688-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ocular Mucous Membrane Pemphigoid after Lyell Syndrome"],"prefix":"10.1016","volume":"119","author":[{"given":"Luca","family":"Fania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"Giannico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Fasciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zampetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ambrogio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Balestrazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Feliciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2011.09.038_bib1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0161-6420(81)35069-6","article-title":"Ocular cicatricial pemphigoid","volume":"88","author":"Mondino","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.038_bib3","first-page":"527","article-title":"Cicatricial pemphigoid","volume":"84","author":"Foster","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2011.09.038_bib4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.preteyeres.2004.05.005","article-title":"Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment","volume":"23","author":"Ahmed","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ophtha.2011.09.038_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archderm.1978.01640150051016","article-title":"Cicatricial pemphigoid and rheumatoid arthritis","volume":"114","author":"Spigel","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/archderm.1981.01650020051025","article-title":"Cicatricial pemphigoid in a patient with systemic lupus erythematosus","volume":"117","author":"Redman","year":"1981","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib7","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.autrev.2008.06.004","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Borchers","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ophtha.2011.09.038_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2332\/allergolint.55.9","article-title":"Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding","volume":"55","author":"French","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.ophtha.2011.09.038_bib9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archderm.1995.01690170046006","article-title":"Metabolic predisposition to cutaneous adverse drug reactions","volume":"131","author":"Wolkenstein","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008571-199508000-00011","article-title":"A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Wolkenstein","year":"1995","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.ophtha.2011.09.038_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-0625.1995.tb00211.x","article-title":"Low N-acetylating capacity in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"4","author":"Dietrich","year":"1995","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib12","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1001\/jama.1991.03470110089038","article-title":"Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome","volume":"266","author":"Chan","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2011.09.038_bib13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/bjo.2006.109124","article-title":"The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy","volume":"91","author":"De Rojas","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00510366","article-title":"Induced pemphigus","volume":"274","author":"Ruocco","year":"1982","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ophtha.2011.09.038_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.radonc.2006.11.013","article-title":"Bullous pemphigoid (BP) induced by radiotherapy","volume":"82","author":"Mul","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0161-6420(86)33675-3","article-title":"Drug induced cicatricial pemphigoid affecting the conjunctiva: light and electron microscopic features","volume":"93","author":"Pouliquen","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.038_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/02713689609000763","article-title":"Differences in the antibasement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid","volume":"15","author":"Bhol","year":"1996","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2011.09.038_bib18","first-page":"191","article-title":"Mucous membrane pemphigoid: clinical aspects, immunopathological features and therapy","volume":"17","author":"Bruch-Gerharz","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/1523-1747.ep12332352","article-title":"Significantly increased occurrence of HLA-DQB1*0301 allele in patients with ocular cicatricial pemphigoid","volume":"108","author":"Chan","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib20","doi-asserted-by":"crossref","first-page":"11579","DOI":"10.1073\/pnas.88.24.11579","article-title":"Association of DQw7(DQB1*0301) with ocular cicatricial pemphigoid","volume":"88","author":"Ahmed","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ophtha.2011.09.038_bib21","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ophtha.2011.09.038_bib22","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archderm.1987.01660330082014","article-title":"Genetic susceptibility to toxic epidermal necrolysis","volume":"123","author":"Roujeau","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib23","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0161-6420(96)30491-0","article-title":"HLA typing in patients with ocular manifestations of Stevens-Johnson syndrome","volume":"103","author":"Power","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.038_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/07853890701753664","article-title":"Stevens-Johnson syndrome: pathogenesis, diagnosis, and management","volume":"40","author":"Hazin","year":"2008","journal-title":"Ann Med"},{"key":"10.1016\/j.ophtha.2011.09.038_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(99)03007-X","article-title":"Pemphigus and bullous pemphigoid","volume":"354","author":"Nousari","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2011.09.038_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0161-6420(93)31644-1","article-title":"The conjunctiva in acute and chronic mucous membrane pemphigoid: an immunohistochemical analysis","volume":"100","author":"Bernauer","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.038_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.all.0000244799.33734.d4","article-title":"Ocular cicatricial pemphigoid","volume":"6","author":"Hingorani","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/MOP.0b013e32832d1fef","article-title":"An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"21","author":"Koh","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.ophtha.2011.09.038_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2133.2006.07398.x","article-title":"Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"155","author":"Caproni","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1067\/mjd.2002.120473","article-title":"Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis","volume":"47","author":"Correia","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib31","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib32","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2332\/allergolint.55.9","article-title":"Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding","volume":"55","author":"French","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.ophtha.2011.09.038_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1523-1747.2000.00037.x","article-title":"Death receptors in cutaneous biology and disease","volume":"115","author":"Wehrli","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib35","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(97)11369-1","article-title":"Toxic epidermal necrolysis","volume":"351","author":"Becker","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2011.09.038_bib36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/1523-1747.ep12543806","article-title":"Erythema multiforme: direct immunofluorescence studies and detection of circulating immune complexes","volume":"74","author":"Bushkell","year":"1980","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib37","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/1523-1747.ep12543789","article-title":"Immune complexes in erythema multiforme and the Stevens-Johnson syndrome","volume":"74","author":"Wuepper","year":"1980","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ophtha.2003.03.001","article-title":"Mucous membrane pemphigoid and pseudopemphigoid","volume":"111","author":"Thorne","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.038_bib39","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0161-6420(95)30896-2","article-title":"Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid","volume":"102","author":"Power","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.038_bib40","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1073\/pnas.93.25.14714","article-title":"Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization","volume":"93","author":"Tyagi","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ophtha.2011.09.038_bib41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/1523-1747.ep12366078","article-title":"Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid","volume":"101","author":"Smith","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib42","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archderm.1993.01680250060007","article-title":"Immune-mediated subepithelial blistering diseases of mucous membranes","volume":"129","author":"Chan","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2133.1988.tb01776.x","article-title":"Immunofluorescent studies in ocular cicatricial pemphigoid","volume":"118","author":"Leonard","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib44","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1684\/ejd.2009.0740","article-title":"Immune diagnosis of pure ocular mucous membrane pemphigoid: indirect immunofluorescence versus immunoblot","volume":"19","author":"Jonkman","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib45","first-page":"157","article-title":"Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"145","author":"Guendry","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2011.09.038_bib46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ophtha.2010.06.035","article-title":"Ocular features and histopathologic changes during follow-up of toxic epidermal necrolysis","volume":"118","author":"L\u00f3pez-Garc\u00eda","year":"2011","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011008955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011008955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:02:22Z","timestamp":1758981742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642011008955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0161642011008955"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2011.09.038","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Mucous Membrane Pemphigoid after Lyell Syndrome","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2011.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}